Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-553-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- The study was conducted between 11 May 1977 and 02 August 1977.
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Documentation insufficient for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Sensitisation was induced in guinea pigs by intradermal injections of both test substance and Freunds Complete Adjuvant and the induction process supplemented seven days later by test substance applied to the shoulder injection sites under occlusion. Fourteen days later, the animals were challenged by occluded patch. Further challenges were made at weekly intervals as required.
- GLP compliance:
- no
- Remarks:
- Study pre-dates GLP
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Reaction mass of 2,4-dimethyl-6-phenyl-3,6-dihydro-2H-pyran and 2-methyl-4-methylene-6-phenyltetrahydro-2H-pyran and 4,6-dimethyl-2-phenyl-3,6-dihydro-2H-pyran
- Molecular formula:
- C13H160
- IUPAC Name:
- Reaction mass of 2,4-dimethyl-6-phenyl-3,6-dihydro-2H-pyran and 2-methyl-4-methylene-6-phenyltetrahydro-2H-pyran and 4,6-dimethyl-2-phenyl-3,6-dihydro-2H-pyran
- Test material form:
- other: Liquid
- Details on test material:
- Name: Pelargene
Chemical name: 2,4-dimethyl-6-phenyldihydropyran
Appearance: Colourless liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Weight - Approximately 320 g
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- no data
- Concentration / amount:
- Induction (intradermal injection): 0.5 %
Induction (covered patch application): 15 %
Challenge (covered patch application): 5 %
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- no data
- Concentration / amount:
- Induction (intradermal injection): 0.5 %
Induction (covered patch application): 15 %
Challenge (covered patch application): 5 %
- No. of animals per dose:
- 10 test animals
- Details on study design:
- Preliminary irritation tests were performed in guinea pigs to determine concentrations of test substance suitable for induction of sensitisation and for sensitisation challenge. Guinea pigs are then treated by intradermal injection in the shoulder region to induce sensitisation and seven days later the sensitisation is boosted by an occluded patch placed over the injection site. 14 days later the animals are challenged on the flank by occluded patch, with further challenges made at weekly or greater intervals as required.
The method is intended to follow as closely as possible that described by Magnusson and Kligman, except that 10 test animals. 4 treated controls and 4 untreated controls were used.
For each of the ten test animals six 0.1 mL intradermal injections were made close together within a 2 x 4 cm area of the shoulder region as follows:
Two injections of test substance in solvent at the chosen intradermal injection concentration,
Two injections of test substance at the chosen intradermal injection concentration in 50 % Complete Freunds Adjuvant in saline.
Two injections of 50 % Complete Freunds Adjuvant in saline.
Seven days later, sensitisation was boosted by placing over the shoulder injections site a 2 x 4 cm filter paper patch saturated with test substance at the selected concentration. The patch was occluded with Blendtherm and held in place by Poroplast, and was left in place for 48 hours.
Fourteen days after application of the shoulder patch, the guinea pigs were challenged on the flank by occluded patch. For each animal an 8 mm diameter filter paper patch in a patch test cup was saturated with test solution and the cup applied to the shaved flank. It was held in place by Poroplast wound around the trunk. 24 hours later, the patch was removed and the reaction site examined 24 and 248 hours after removal of the patch.
Scoring
Reactions were examined under constant artificial daylight 24 hours and 48 hours after removal of the challenge patches and are scored on a scale from 0 to +++. Reactions were considered positive if they were + or greater and there was no irritation reactions in controls. - Challenge controls:
- Treated controls
Four guinea pigs of the same sex and weighing approximately 320 g were treated exactly as for the test animals, except that the test substance was omitted from the intradermal injection and covered patch induction procedures. The animals were challenged exactly as for the test animals.
Untreated controls
At each challenge four previously untreated animals of the same sex and weighing the same as the test animals were “challenged” as for the test animals. - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- One animal died during the study.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: One animal died during the study..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 5 %. No with. + reactions: 1.0. Total no. in groups: 9.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 5 %. No with. + reactions: 1.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 3
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2.5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 3. . Hours after challenge: 24.0. Group: test group. Dose level: 2.5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 3
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2.5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 3. . Hours after challenge: 48.0. Group: test group. Dose level: 2.5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 3
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 3. . Hours after challenge: 24.0. Group: test group. Dose level: 5 %. No with. + reactions: 1.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 3
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 3. . Hours after challenge: 48.0. Group: test group. Dose level: 5 %. No with. + reactions: 1.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 4
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2.5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 4. . Hours after challenge: 24.0. Group: test group. Dose level: 2.5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 4
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2.5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 4. . Hours after challenge: 48.0. Group: test group. Dose level: 2.5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 4
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 4. . Hours after challenge: 24.0. Group: test group. Dose level: 5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- other: Challenge 4
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: other: Challenge 4. . Hours after challenge: 48.0. Group: test group. Dose level: 5 %. No with. + reactions: 0.0. Total no. in groups: 9.0.
Any other information on results incl. tables
None out of 10 guinea pigs tested were sensitised after four challenges.
Pelargene is probably not a sensitiser, although two challenges at 5 % suggest sensitisation, this response was not consistent.
Guinea pigs |
Challenge 1 |
Challenge 2 |
Challenge 3 |
Challenge 4 |
||||||||||
No. |
Ear No. |
Sex |
5 % |
5 % |
2.5 % |
5 % |
2.5 % |
5 % |
||||||
24 h |
48 h |
24 h |
48 h |
24 h |
48 h |
24 h |
48 h |
24 h |
48 h |
24 h |
48 h |
|||
Test Substance |
||||||||||||||
1 |
4459 |
F |
± |
± |
± |
+ |
0 |
0 |
0 |
± |
?0 |
0 |
0 |
0 |
2 |
4268 |
F |
0 |
0 |
± |
0 |
0 |
± |
0 |
± |
?0 |
0 |
0 |
0 |
3 |
R4167 |
F |
0 |
0 |
± |
± |
0 |
0 |
0 |
0 |
?0 |
0 |
?0 |
0 |
4 |
4622 |
F |
0 |
0 |
0 |
0 |
0 |
0 |
± |
± |
0 |
0 |
0 |
0 |
5 |
4106 |
F |
?0 |
± |
?0 |
0 |
0 |
0 |
0 |
0 |
± |
0 |
0 |
0 |
6 |
4421 |
F |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
5695 |
M |
0 |
0 |
± |
0 |
0 |
0 |
?0 |
0 |
?0 |
0 |
0 |
0 |
8 |
4625 |
M |
± |
± |
+ |
+ / ++ |
0 |
0 |
+ |
+ / ++ |
?0 |
0 |
0 |
0 |
9 |
4690 |
M |
|
|
|
|
|
|
|
|
|
|
|
|
10 |
4224 |
M |
?0 |
0 |
± |
± |
0 |
?0 |
0 |
0 |
± |
?0 |
0 |
0 |
Treated Controls |
||||||||||||||
1 |
R599 |
F |
0 |
± |
|
|
|
|
|
|
|
|
|
|
2 |
4280 |
F |
?0 |
0 |
|
|
|
|
|
|
|
|
|
|
3 |
4402 |
F |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
4 |
4255 |
F |
0 |
± |
|
|
|
|
|
|
|
|
|
|
Untreated Controls |
||||||||||||||
1 |
4353 |
M |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
2 |
4436 |
M |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
3 |
R4187 |
M |
?± |
?± |
|
|
|
|
|
|
|
|
|
|
4 |
4094 |
M |
± |
± |
|
|
|
|
|
|
|
|
|
|
1 |
4513 |
F |
|
|
0 |
?0 |
|
|
|
|
|
|
|
|
2 |
4475 |
F |
|
|
± |
± |
|
|
|
|
|
|
|
|
3 |
3282 |
F |
|
|
0 |
0 |
|
|
|
|
|
|
|
|
4 |
4726 |
F |
|
|
?± |
?± |
|
|
|
|
|
|
|
|
1 |
5551 |
M |
|
|
|
|
0 |
0 |
0 |
0 |
|
|
|
|
2 |
5274 |
M |
|
|
|
|
0 |
0 |
0 |
0 |
|
|
|
|
3 |
5164 |
M |
|
|
|
|
0 |
0 |
0 |
?0 |
|
|
|
|
4 |
5051 |
M |
|
|
|
|
0 |
0 |
0 |
0 |
|
|
|
|
1 |
4956 |
M |
|
|
|
|
|
|
|
|
0 |
0 |
0 |
0 |
2 |
5425 |
M |
|
|
|
|
|
|
|
|
0 |
0 |
0 |
0 |
3 |
5344 |
M |
|
|
|
|
|
|
|
|
0 |
0 |
?0 |
0 |
4 |
5566 |
M |
|
|
|
|
|
|
|
|
0 |
0 |
0 |
0 |
0 = No reaction
±= barely perceptible erythema
+= Scattered, mild erythema (faint pink)
++ = Moderate and diffuse erythema (pale pink)
+++ = Intense erythema (deep pink) and oedema
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- None of the 10 guinea pigs tested were sensitised after four challenges.
- Executive summary:
The skin sensitisation potential of the test substance was assessed. None of the 10 guinea pigs tested were sensitised after four challenges.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.